Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
Clinical trial NCT02568449 · COMPLETED
Trial details
- NCT number
- NCT02568449
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-15
- Primary completion
- 2017-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.